PetIQ, Inc. operates as a pet health and wellness company. It provides veterinarian services and veterinarian-grade pet products, including prescription (Rx) medications, over-the-counter (OTC) flea and tick preventatives, and health and wellness products for dogs and cats. The company offers pet prescription medications, including products for arthritis, thyroid, and diabetes and pain treatments, as well as heartworm preventatives, antibiotics, and other specialty medications; over-the-counter medications and supplies, such as flea and tick control products in various forms comprising spot on treatments, chewables, and collars; and health and wellness products consisting of specialty treats and other pet products, which include dental treats and nutritional supplements. The company provides its products primarily under the VetIQ, PetAction Plus, Advecta, PetLock Plus, and TruProfen brands. It sells its products through approximately 60,000 points of distribution across retail and e-commerce channels. PetIQ, Inc. was founded in 2010 and is headquartered in Eagle, Idaho.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Drugs, proprietaries, & sundries
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:PETQ
CUSIPN/A
Phone208-939-8900
Debt
Debt-to-Equity Ratio0.56
Current Ratio2.00
Quick Ratio0.90
Price-To-Earnings
Trailing P/E Ratio86.00
Forward P/E Ratio44.13
P/E Growth1.77
Sales & Book Value
Annual Sales$266.69 million
Price / Sales3.23
Cash Flow$0.4060 per share
Price / Cash82.61
Book Value$4.88 per share
Price / Book6.87
Profitability
EPS (Most Recent Fiscal Year)$0.39
Net Income$-3,490,000.00
Net Margins-0.76%
Return on Equity11.40%
Return on Assets6.52%
Miscellaneous
Employees225
Outstanding Shares25,690,000
Market Cap$865.24 million
PetIQ (NASDAQ:PETQ) Frequently Asked Questions
What is PetIQ's stock symbol?
PetIQ trades on the NASDAQ under the ticker symbol "PETQ."
How were PetIQ's earnings last quarter?
PetIQ Inc (NASDAQ:PETQ) posted its quarterly earnings data on Tuesday, August, 14th. The company reported $0.41 EPS for the quarter, topping the consensus estimate of $0.39 by $0.02. The business had revenue of $171.10 million for the quarter, compared to analyst estimates of $148.48 million. PetIQ had a negative net margin of 0.76% and a positive return on equity of 11.40%. The company's revenue was up 96.2% compared to the same quarter last year. View PetIQ's Earnings History.
When is PetIQ's next earnings date?
What price target have analysts set for PETQ?
5 brokers have issued 1-year target prices for PetIQ's stock. Their predictions range from $32.00 to $50.00. On average, they anticipate PetIQ's share price to reach $43.20 in the next year. This suggests a possible upside of 28.8% from the stock's current price. View Analyst Price Targets for PetIQ.
What is the consensus analysts' recommendation for PetIQ?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PetIQ in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for PetIQ.
What are Wall Street analysts saying about PetIQ stock?
Here are some recent quotes from research analysts about PetIQ stock:
- 1. Jefferies Financial Group Inc analysts commented, "Median short interest for the Beverages group decreased -1.6% since 7/31, while positions against Household Products decreased -6.2% during the same period. Among the largest decreases in Beverages since 7/31 were KDP (-34%), PEP (-20%), and KO (-6%); among the largest decreases in HPC were KMB (-17%), CLX (-15%), and EPC (-14%). Median days to cover for Beverages are 2.3 and 6.7 for HPC. On the long side, we favor and MNST. Short interest update: Median short interest (SI) for the Beverages group decreased -1.6% since 7/31, while positions against the HPC group decreased -6.2%. In aggregate, short interest for the overall staples group decreased -2.5% since 7/31." (8/24/2018)
- 2. According to Zacks Investment Research, "PetIQ, Inc. is a pet medication and wellness company. Its product consists of Rx Medications, OTC Medications and Supplies, Health and Wellness Products. The Company serves retail stores across the mass, club, grocery, pharmacy and e-commerce channels. PetIQ, Inc. is based in Eagle, United States. " (6/6/2018)
Who are some of PetIQ's key competitors?
Who are PetIQ's key executives?
PetIQ's management team includes the folowing people:
- Mr. McCord Christensen, Chairman & CEO (Age 46)
- Mr. John Newland, CFO & Corp. Sec. (Age 54)
When did PetIQ IPO?
(PETQ) raised $86 million in an initial public offering on Friday, July 21st 2017. The company issued 5,700,000 shares at $14.00-$16.00 per share. Jefferies and William Blair acted as the underwriters for the IPO and Oppenheimer, Raymond James and SunTrust Robinson Humphrey were co-managers.
Who are PetIQ's major shareholders?
PetIQ's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include State of New Jersey Common Pension Fund D (3.89%), Peregrine Capital Management LLC (2.20%), Essex Investment Management Co. LLC (0.64%), Supplemental Annuity Collective Trust of NJ (0.12%), NJ State Employees Deferred Compensation Plan (0.09%) and Campbell Newman Asset Management Inc. (0.06%). Company insiders that own PetIQ stock include Ecp Helios Partners Iv, LP, James Nathan Clarke, John Newland, Mccord Christensen, Ronald Kennedy and Will Santana. View Institutional Ownership Trends for PetIQ.
Which major investors are selling PetIQ stock?
PETQ stock was sold by a variety of institutional investors in the last quarter, including NJ State Employees Deferred Compensation Plan, Essex Investment Management Co. LLC, New Jersey Better Educational Savings Trust and Supplemental Annuity Collective Trust of NJ. Company insiders that have sold PetIQ company stock in the last year include Ecp Helios Partners Iv, LP, James Nathan Clarke, John Newland, Mccord Christensen and Will Santana. View Insider Buying and Selling for PetIQ.
Which major investors are buying PetIQ stock?
PETQ stock was bought by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC, State of New Jersey Common Pension Fund D and Campbell Newman Asset Management Inc.. View Insider Buying and Selling for PetIQ.
How do I buy shares of PetIQ?
Shares of PETQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is PetIQ's stock price today?
One share of PETQ stock can currently be purchased for approximately $33.54.
How big of a company is PetIQ?
PetIQ has a market capitalization of $865.24 million and generates $266.69 million in revenue each year. The company earns $-3,490,000.00 in net income (profit) each year or $0.39 on an earnings per share basis. PetIQ employs 225 workers across the globe.
What is PetIQ's official website?
How can I contact PetIQ?
PetIQ's mailing address is 923 S. Bridgeway Pl., EAGLE ID, 83616. The company can be reached via phone at 208-939-8900 or via email at [email protected]
MarketBeat Community Rating for PetIQ (NASDAQ PETQ)
MarketBeat's community ratings are surveys of what our community members think about PetIQ and other stocks. Vote "Outperform" if you believe PETQ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PETQ will underperform the S&P 500 over the long term. You may vote once every thirty days.
